Biotech Week Boston
When
Where
What
Join us at Biotech Week Boston 2025, where Intellias Healthcare & Life Science experts will demonstrate how we are pioneering a collaborative and efficient future in bioprocessing to benefit patients, researchers, and industry alike. Experience innovations from cell line engineering to downstream manufacturing, powered by AI and digital automation in a mobile-first world. Immerse yourself in emerging trends across biologics, vaccines, and advanced therapies as our team showcases cutting-edge solutions that redefine bioprocessing—unlocking new horizons of precision, scalability, and therapeutic impact. Don’t miss the opportunity to lead the technological evolution in life sciences—experience the future with Intellias at Biotech Week Boston 2025.
Attendees
Roy Wills
Head of HCLS, Pharma./Med. Devices & Alliances
Technology and business leader, Roy Wills serves as the SVP, Head of HCLS, Pharma./Med. Devices & Alliances at Intellias. In this role, he shapes and drives the company’s strategic direction in healthcare and life sciences, forging alliances and partnerships that empower Intellias to deliver exceptional value to clients across the globe. With over 25 years of experience in engineering services and healthcare transformation, Roy brings a wealth of expertise to supervising cross-functional teams and orchestrating the development of cutting-edge, scalable solutions.
Tom Riley
Senior Client Executive Director, Digital, North America
Technology and business growth leader, Tom Riley is the Senior Client Executive Director, Digital, North America at Intellias. He spearheads strategic client engagements, building long-term partnerships and delivering transformative digital solutions that empower organizations to achieve sustainable growth. With over two decades of experience in business development and sales leadership, Tom combines deep industry expertise with a results-driven approach, guiding cross-functional teams to create impactful, client-focused outcomes.
Get in touch with us. We'd love to hear from you.